• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于转录组学的天然化合物,莪术二酮,作为 PRC2 调节剂的重新定位。

Transcriptomics-Based Repositioning of Natural Compound, Eudesmin, as a PRC2 Modulator.

机构信息

School of Pharmacy, Sungkyunkwan University, Suwon 16419, Korea.

College of Pharmacy, Yonsei Institute of Pharmaceutical Sciences, International Campus, Yonsei University, Incheon 21983, Korea.

出版信息

Molecules. 2021 Sep 18;26(18):5665. doi: 10.3390/molecules26185665.

DOI:10.3390/molecules26185665
PMID:34577136
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8465685/
Abstract

Extensive epigenetic remodeling occurs during the cell fate determination of stem cells. Previously, we discovered that eudesmin regulates lineage commitment of mesenchymal stem cells through the inhibition of signaling molecules. However, the epigenetic modulations upon eudesmin treatment in genomewide level have not been analyzed. Here, we present a transcriptome profiling data showing the enrichment in PRC2 target genes by eudesmin treatment. Furthermore, gene ontology analysis showed that PRC2 target genes downregulated by eudesmin are closely related to Wnt signaling and pluripotency. We selected as an eudesmin-dependent potential top hub gene in the Wnt signaling and pluripotency. Through the ChIP-qPCR and RT-qPCR, we found that eudesmin treatment increased the occupancy of PRC2 components, EZH2 and SUZ12, and H3K27me3 level on the promoter region of , downregulating its transcription level. According to the analysis of GEO profiles, DEGs by depletion of Oct4 showed an opposite pattern to DEGs by eudesmin treatment. Indeed, the expression of pluripotency markers, Oct4, Sox2, and Nanog, was upregulated upon eudesmin treatment. This finding demonstrates that pharmacological modulation of PRC2 dynamics by eudesmin might control Wnt signaling and maintain pluripotency of stem cells.

摘要

在干细胞的细胞命运决定过程中会发生广泛的表观遗传重塑。此前,我们发现,桉脂素通过抑制信号分子来调节间充质干细胞的谱系承诺。然而,桉脂素处理在全基因组水平上的表观遗传调节尚未被分析。在这里,我们呈现了一个转录组谱分析数据,显示了桉脂素处理后 PRC2 靶基因的富集。此外,基因本体分析表明,桉脂素下调的 PRC2 靶基因与 Wnt 信号和多能性密切相关。我们选择 作为 Wnt 信号和多能性中桉脂素依赖的潜在顶级枢纽基因。通过 ChIP-qPCR 和 RT-qPCR,我们发现桉脂素处理增加了 PRC2 成分 EZH2 和 SUZ12 以及 H3K27me3 在 启动子区域的占有率,下调其转录水平。根据 GEO 图谱的分析,Oct4 耗竭的 DEGs 与桉脂素处理的 DEGs 呈现相反的模式。事实上,桉脂素处理后多能性标记物 Oct4、Sox2 和 Nanog 的表达上调。这一发现表明,桉脂素对 PRC2 动力学的药理学调节可能控制 Wnt 信号并维持干细胞的多能性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f24/8465685/ddb346f1db9a/molecules-26-05665-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f24/8465685/0df0aa7b807b/molecules-26-05665-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f24/8465685/69b7f881cbe5/molecules-26-05665-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f24/8465685/2e9d5ffee1d4/molecules-26-05665-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f24/8465685/480ffc8926fc/molecules-26-05665-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f24/8465685/ddb346f1db9a/molecules-26-05665-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f24/8465685/0df0aa7b807b/molecules-26-05665-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f24/8465685/69b7f881cbe5/molecules-26-05665-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f24/8465685/2e9d5ffee1d4/molecules-26-05665-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f24/8465685/480ffc8926fc/molecules-26-05665-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f24/8465685/ddb346f1db9a/molecules-26-05665-g005.jpg

相似文献

1
Transcriptomics-Based Repositioning of Natural Compound, Eudesmin, as a PRC2 Modulator.基于转录组学的天然化合物,莪术二酮,作为 PRC2 调节剂的重新定位。
Molecules. 2021 Sep 18;26(18):5665. doi: 10.3390/molecules26185665.
2
Dual inhibition of enhancer of zeste homolog 1/2 overactivates WNT signaling to deplete cancer stem cells in multiple myeloma.双重抑制增强子结合蛋白同源物 1/2 可过度激活 WNT 信号通路,从而耗尽多发性骨髓瘤中的癌症干细胞。
Cancer Sci. 2019 Jan;110(1):194-208. doi: 10.1111/cas.13840. Epub 2018 Nov 16.
3
Deletion of Polycomb Repressive Complex 2 From Mouse Intestine Causes Loss of Stem Cells.从鼠肠中删除 Polycomb 抑制复合物 2 导致干细胞丢失。
Gastroenterology. 2016 Oct;151(4):684-697.e12. doi: 10.1053/j.gastro.2016.06.020. Epub 2016 Jun 21.
4
PRC2 Is Dispensable for β-Catenin-Mediated Repression of Chondrogenesis in the Mouse Embryonic Cranial Mesenchyme.PRC2对于β-连环蛋白介导的小鼠胚胎颅间充质软骨生成抑制作用是可有可无的。
G3 (Bethesda). 2018 Feb 2;8(2):491-503. doi: 10.1534/g3.117.300311.
5
PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs.PRC2决定外胚层谱系,并在已分化而非原始态的胚胎干细胞中维持多能性。
Nat Commun. 2017 Sep 22;8(1):672. doi: 10.1038/s41467-017-00668-4.
6
JARID2 and the PRC2 complex regulate skeletal muscle differentiation through regulation of canonical Wnt signaling.JARID2 和 PRC2 复合物通过调节经典 Wnt 信号通路调节骨骼肌分化。
Epigenetics Chromatin. 2018 Aug 17;11(1):46. doi: 10.1186/s13072-018-0217-x.
7
Mutations and deletions of PRC2 in prostate cancer.前列腺癌中PRC2的突变与缺失
Bioessays. 2016 May;38(5):446-54. doi: 10.1002/bies.201500162. Epub 2016 Mar 22.
8
Bach1 regulates self-renewal and impedes mesendodermal differentiation of human embryonic stem cells.Bach1 调控人胚胎干细胞的自我更新并阻碍中胚层分化。
Sci Adv. 2019 Mar 13;5(3):eaau7887. doi: 10.1126/sciadv.aau7887. eCollection 2019 Mar.
9
Polycomb complex mediated epigenetic reprogramming alters TGF-β signaling via a novel EZH2/miR-490/TGIF2 axis thereby inducing migration and EMT potential in glioblastomas.多梳复合物介导的表观遗传重编程通过新型 EZH2/miR-490/TGIF2 轴改变 TGF-β 信号通路,从而诱导脑胶质瘤的迁移和 EMT 潜能。
Int J Cancer. 2019 Sep 1;145(5):1254-1269. doi: 10.1002/ijc.32360. Epub 2019 May 10.
10
NBAT1 suppresses breast cancer metastasis by regulating DKK1 via PRC2.NBAT1通过PRC2调控DKK1来抑制乳腺癌转移。
Oncotarget. 2015 Oct 20;6(32):32410-25. doi: 10.18632/oncotarget.5609.

本文引用的文献

1
HPV-mediated nuclear export of HP1γ drives cervical tumorigenesis by downregulation of p53.HPV 介导的 HP1γ 核输出通过下调 p53 驱动宫颈癌发生。
Cell Death Differ. 2020 Sep;27(9):2537-2551. doi: 10.1038/s41418-020-0520-5. Epub 2020 Mar 23.
2
Tazemetostat: First Approval.他泽莫司他:美国首次批准
Drugs. 2020 Apr;80(5):513-521. doi: 10.1007/s40265-020-01288-x.
3
Eudesmin exerts antitumor effects by down-regulating EZH2 expression in nasopharyngeal carcinoma cells.莪术二酮通过下调鼻咽癌细胞中 EZH2 的表达发挥抗肿瘤作用。
Chem Biol Interact. 2019 Jul 1;307:51-57. doi: 10.1016/j.cbi.2019.04.028. Epub 2019 Apr 24.
4
Eudesmin impairs adipogenic differentiation via inhibition of S6K1 signaling pathway.柚皮苷通过抑制 S6K1 信号通路来抑制脂肪生成分化。
Biochem Biophys Res Commun. 2018 Nov 10;505(4):1148-1153. doi: 10.1016/j.bbrc.2018.09.188. Epub 2018 Oct 11.
5
Mtf2-PRC2 control of canonical Wnt signaling is required for definitive erythropoiesis.决定性红细胞生成需要Mtf2-PRC2对经典Wnt信号通路的调控。
Cell Discov. 2018 May 1;4:21. doi: 10.1038/s41421-018-0022-5. eCollection 2018.
6
Eudesmin attenuates -induced epithelial autophagy and apoptosis and leads to eradication of infection.泽兰苦素可减轻诱导的上皮细胞自噬和凋亡,并导致感染的根除。
Exp Ther Med. 2018 Mar;15(3):2388-2396. doi: 10.3892/etm.2018.5701. Epub 2018 Jan 4.
7
The antitumour effects of eudesmin on lung cancer by inducing apoptosis via mitochondria-mediated pathway in the tumour cells.莪术酮通过诱导肿瘤细胞中线粒体介导的途径诱导细胞凋亡对肺癌的抗肿瘤作用。
Pharm Biol. 2017 Dec;55(1):2259-2263. doi: 10.1080/13880209.2017.1401647.
8
Naturally occurring anti-cancer agents targeting EZH2.靶向 EZH2 的天然抗癌药物。
Cancer Lett. 2017 Aug 1;400:325-335. doi: 10.1016/j.canlet.2017.03.020. Epub 2017 Mar 18.
9
Polycomb Repressive Complex 2 Enacts Wnt Signaling in Intestinal Homeostasis and Contributes to the Instigation of Stemness in Diseases Entailing Epithelial Hyperplasia or Neoplasia.多梳抑制复合物2在肠道稳态中发挥Wnt信号作用,并在导致上皮增生或肿瘤形成的疾病中促使干细胞特性的激发。
Stem Cells. 2017 Feb;35(2):445-457. doi: 10.1002/stem.2479. Epub 2016 Sep 13.
10
Association between EZH2 expression, silencing of tumor suppressors and disease outcome in solid tumors.实体瘤中EZH2表达、肿瘤抑制因子沉默与疾病预后之间的关联。
Cell Cycle. 2016 Sep;15(17):2256-62. doi: 10.1080/15384101.2016.1208872. Epub 2016 Jul 15.